dihexa cognitive enhancement 2019 chemically induced Brain peptides in Alzheimer's disease - pathophysiology and therapeutic advances | Cell and Tissue Research Dihexa (PNB-0408) | c-Met/HGFR Activator
Description
Selank administration affects the expression of some genes involved in GABAergic neurotransmission
I said no
While clinical evidence remains limited, both peptides may have potential applications in supporting chondrocyte viability and potentially attenuating cartilage degradation processes associated with osteoarthritic conditions
Serious side effects are rare but will be closely monitored
